215 related articles for article (PubMed ID: 8912798)
1. Perinatal delta 9-tetrahydrocannabinol exposure in rats modifies the responsiveness of midbrain dopaminergic neurons in adulthood to a variety of challenges with dopaminergic drugs.
García L; de Miguel R; Ramos JA; Fernàndez-Ruiz JJ
Drug Alcohol Depend; 1996 Nov; 42(3):155-66. PubMed ID: 8912798
[TBL] [Abstract][Full Text] [Related]
2. Perinatal delta(9)-tetrahydrocannabinol exposure alters the responsiveness of hypothalamic dopaminergic neurons to dopamine-acting drugs in adult rats.
García-Gil L; De Miguel R; Muñoz RM; Cebeira M; Villanua MA; Ramos JA; Fernández-Ruiz JJ
Neurotoxicol Teratol; 1997; 19(6):477-87. PubMed ID: 9392783
[TBL] [Abstract][Full Text] [Related]
3. Perinatal delta9-tetrahydrocannabinol exposure augmented the magnitude of motor inhibition caused by GABA(B), but not GABA(A), receptor agonists in adult rats.
Garcia-Gil L; de Miguel R; Romero J; Perez A; Ramos JA; Fernández-Ruiz JJ
Neurotoxicol Teratol; 1999; 21(3):277-83. PubMed ID: 10386831
[TBL] [Abstract][Full Text] [Related]
4. An acute dose of delta 9-tetrahydrocannabinol affects behavioral and neurochemical indices of mesolimbic dopaminergic activity.
Navarro M; Fernández-Ruiz JJ; de Miguel R; Hernández ML; Cebeira M; Ramos JA
Behav Brain Res; 1993 Oct; 57(1):37-46. PubMed ID: 8292253
[TBL] [Abstract][Full Text] [Related]
5. Motor behavior and nigrostriatal dopaminergic activity in adult rats perinatally exposed to cannabinoids.
Navarro M; Rodríguez de Fonseca F; Hernández ML; Ramos JA; Fernández-Ruiz JJ
Pharmacol Biochem Behav; 1994 Jan; 47(1):47-58. PubMed ID: 7906890
[TBL] [Abstract][Full Text] [Related]
6. Effects of perinatal exposure to delta 9-tetrahydrocannabinol on operant morphine-reinforced behavior.
González B; de Miguel R; Martín S; Pérez-Rosado A; Romero J; García-Lecumberri C; Fernández-Ruiz J; Ramos JA; Ambrosio E
Pharmacol Biochem Behav; 2003 Jun; 75(3):577-84. PubMed ID: 12895675
[TBL] [Abstract][Full Text] [Related]
7. Perinatal delta9-tetrahydrocannabinol exposure did not alter dopamine transporter and tyrosine hydroxylase mRNA levels in midbrain dopaminergic neurons of adult male and female rats.
García-Gil L; Ramos JA; Rubino T; Parolaro D; Fernández-Ruiz JJ
Neurotoxicol Teratol; 1998; 20(5):549-53. PubMed ID: 9761594
[TBL] [Abstract][Full Text] [Related]
8. Perinatal exposure to delta 9-tetrahydrocannabinol increases presynaptic dopamine D2 receptor sensitivity: a behavioral study in rats.
Moreno M; Trigo JM; Escuredo L; Rodríguez de Fonseca F; Navarro M
Pharmacol Biochem Behav; 2003 Jun; 75(3):565-75. PubMed ID: 12895674
[TBL] [Abstract][Full Text] [Related]
9. The endogenous cannabinoid receptor ligand, anandamide, inhibits the motor behavior: role of nigrostriatal dopaminergic neurons.
Romero J; García L; Cebeira M; Zadrozny D; Fernández-Ruiz JJ; Ramos JA
Life Sci; 1995; 56(23-24):2033-40. PubMed ID: 7776829
[TBL] [Abstract][Full Text] [Related]
10. Cannabinoid receptor binding and mRNA levels in several brain regions of adult male and female rats perinatally exposed to delta9-tetrahydrocannabinol.
García-Gil L; Romero J; Ramos JA; Fernández-Ruiz JJ
Drug Alcohol Depend; 1999 Jun; 55(1-2):127-36. PubMed ID: 10402157
[TBL] [Abstract][Full Text] [Related]
11. Long-term behavioral effects of perinatal exposure to delta 9-tetrahydrocannabinol in rats: possible role of pituitary-adrenal axis.
Rubio P; Rodríguez de Fonseca F; Muñoz RM; Ariznavarreta C; Martín-Calderón JL; Navarro M
Life Sci; 1995; 56(23-24):2169-76. PubMed ID: 7776846
[TBL] [Abstract][Full Text] [Related]
12. Neuronal and astroglial response to pre- and perinatal exposure to delta-9-tetra- hydrocannabinol in the rat substantia nigra.
Suárez I; Bodega G; Ramos JA; Fernández-Ruiz JJ; Fernández B
Dev Neurosci; 2000; 22(4):253-63. PubMed ID: 10965147
[TBL] [Abstract][Full Text] [Related]
13. Delta 9-tetrahydrocannabinol-induced MAPK/ERK and Elk-1 activation in vivo depends on dopaminergic transmission.
Valjent E; Pagès C; Rogard M; Besson MJ; Maldonado R; Caboche J
Eur J Neurosci; 2001 Jul; 14(2):342-52. PubMed ID: 11553284
[TBL] [Abstract][Full Text] [Related]
14. delta 9-Tetrahydrocannabinol affects mesolimbic dopaminergic activity in the female rat brain: interactions with estrogens.
Bonnin A; Fernández-Ruiz JJ; Martín M; Rodríguez de Fonseca F; Hernández ML; Ramos JA
J Neural Transm Gen Sect; 1993; 92(2-3):81-95. PubMed ID: 8103663
[TBL] [Abstract][Full Text] [Related]
15. Acute effects of delta-9-tetrahydrocannabinol on dopaminergic activity in several rat brain areas.
Rodríguez De Fonseca F; Fernández-Ruiz JJ; Murphy LL; Cebeira M; Steger RW; Bartke A; Ramos JA
Pharmacol Biochem Behav; 1992 Jun; 42(2):269-75. PubMed ID: 1321451
[TBL] [Abstract][Full Text] [Related]
16. Effects of perinatal exposure to delta 9-tetrahydrocannabinol on the fetal and early postnatal development of tyrosine hydroxylase-containing neurons in rat brain.
Bonnin A; de Miguel R; Castro JG; Ramos JA; Fernandez-Ruiz JJ
J Mol Neurosci; 1996; 7(4):291-308. PubMed ID: 8968950
[TBL] [Abstract][Full Text] [Related]
17. Motor disturbances induced by an acute dose of delta 9-tetrahydrocannabinol: possible involvement of nigrostriatal dopaminergic alterations.
Navarro M; Fernández-Ruiz JJ; De Miguel R; Hernández ML; Cebeira M; Ramos JA
Pharmacol Biochem Behav; 1993 Jun; 45(2):291-8. PubMed ID: 8392200
[TBL] [Abstract][Full Text] [Related]
18. Sex-dimorphic psychomotor activation after perinatal exposure to (-)-delta 9-tetrahydrocannabinol. An ontogenic study in Wistar rats.
Navarro M; Rubio P; Rodríguez de Fonseca F
Psychopharmacology (Berl); 1994 Dec; 116(4):414-22. PubMed ID: 7701042
[TBL] [Abstract][Full Text] [Related]
19. Time-course of the effects of anandamide, the putative endogenous cannabinoid receptor ligand, on extrapyramidal function.
Romero J; de Miguel R; García-Palomero E; Fernández-Ruiz JJ; Ramos JA
Brain Res; 1995 Oct; 694(1-2):223-32. PubMed ID: 8974649
[TBL] [Abstract][Full Text] [Related]
20. The effects of GBR 12909, a dopamine re-uptake inhibitor, on monoaminergic neurotransmission in rat striatum, limbic forebrain, cortical hemispheres and substantia nigra.
Nissbrandt H; Engberg G; Pileblad E
Naunyn Schmiedebergs Arch Pharmacol; 1991 Jul; 344(1):16-28. PubMed ID: 1663587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
